Evaluation of Platinum Chemotherapy in Combination with HER2-Targeted α-Particle Radiation-Reference-Cited by-同舟云学术

Evaluation of Platinum Chemotherapy in Combination with HER2-Targeted α-Particle Radiation

Published:2013-07 Issue:6 Volume:28 Page:441-449
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Milenic Diane E.¹,Baidoo Kwamena E.¹,Shih Joanna H.²,Wong Karen J.³,Brechbiel Martin W.¹

Affiliation:

1. Radioimmune & Inorganic Chemistry Section, Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

2. Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

3. Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2012.1423

Reference38 articles.

1. Targeting of HER2 Antigen for the Treatment of Disseminated Peritoneal Disease

2. Potentiation of High-LET Radiation by Gemcitabine: Targeting HER2 with Trastuzumab to Treat Disseminated Peritoneal Disease

3. α-Particle Radioimmunotherapy of Disseminated Peritoneal Disease Using a 212Pb-Labeled Radioimmunoconjugate Targeting HER2

4. Multimodality Therapy: Potentiation of High Linear Energy Transfer Radiation with Paclitaxel for the Treatment of Disseminated Peritoneal Disease

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual targeting with 224Ra/212Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach;Frontiers in Medicine;2023-01-17

2. Bismuth nanoparticles against microbial infections;Nanomedicine;2022-11

3. Impact of Alpha-Radiotherapy on the Tumor Microenvironment;Handbook of Cancer and Immunology;2022

4. Why bother with alpha particles?;European Journal of Nuclear Medicine and Molecular Imaging;2021-06-27

5. Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The “Hopeful Eight”;Pharmaceutics;2021-06-18